$RKLB

Should You Ignore Rocket Lab Stock? Why SpaceX May Be the Better Space Stock Today.

Rocket Lab (RKLB) stock fluctuated in August, ending near its starting price. Despite recent successes, including a $12M Space Force contract and an $8B acquisition, investors seem to favor SpaceX (SPCX), which is up 30% in August. SpaceX leads in rocket launches, payload capacity, and reusable technology, with Starship targeting 10,000 launches annually. Rocket Lab's Neutron rocket is delayed, while SpaceX has multiple space ventures, including Starlink and lunar missions.

Original reporting
Published Sep 4, 2026, 12:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 1:23 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Should You Ignore Rocket Lab Stock? Why SpaceX May Be the Better Space Stock Today. — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

New government contracts could improve Rocket Lab's earnings visibility, but execution risk remains.

02

Market read

First disclosure of sizable Space Force contracts to Rocket Lab, offering a potential catalyst for the stock.

03

What to watch

The $981 million contract is an umbrella award; actual cash flow depends on milestone payments and execution risk.

Relevance 7/10Novelty 6/10Timing: mid‑August 2026

Background

The article compares Rocket Lab's recent contract wins and launch activity to SpaceX's larger scale, questioning investor preference.

Company-level read

Ticker impact

$RKLBBullishMedium confidence
Context

Rocket Lab received a $12 million Space Force contract on Aug 18 and a $981 million NITE‑STAR contract on Aug 17, newly disclosed in this article.

Expected impact

Potential short‑term upside of 5‑10% if investors price in the new funding.

Evidence & confidence

Large government contracts are material for a small cap; the market has not yet fully reflected them.

Market effects

Highlights growing U.S. defense spending on commercial launch providers, benefiting the small‑sat launch sector.

U.S. defense contracts may lift other domestic launch firms.

Shows competition between private launch companies for government business worldwide.

Counterpoint

Despite the contracts, Rocket Lab's delayed Neutron launch and modest payload capacity may limit long‑term upside versus SpaceX.

Key entities

  • Rocket Lab

    U.S. listed small‑sat launch provider (ticker RKLB).

  • U.S. Space Force

    Awarded contracts to Rocket Lab for data network and NITE‑STAR programs.

Related articles

$RKLBHighAI 8/10

Rocket Lab Stock Flashes Major Warning Signal

Rocket Lab (RKLB) shares trade at $62.54, below key moving averages, with technical indicators signaling a Sell. Despite this, revenue grew 62% YoY to $234M in Q2, and backlog surged 137% to $2.36B. The company's Neutron rocket development is a key focus, with a launch pad delivery expected in Q4 2026. Investors should monitor moving averages and Neutron progress.

$RKLBMedAI 8/10

Rocket Lab Surges 43.7% in a Year: Is There More Room to Run?

Rocket Lab's shares rose 43.7% in the past year, outperforming its industry. The company's growth is driven by expansions, acquisitions, and U.S. national security opportunities. Rocket Lab's backlog reached $2.36 billion, and it was selected for a $981 million U.S. Space Force program. The company's debt and liquidity positions are strong, with a low debt-to-capital ratio and high current ratio. Rocket Lab's forward P/S ratio is 31.3X, higher than its industry average. According to Zacks, earni